Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Kauffman Insider Profile
11 Followers
Michael Kauffman, Director at Karyopharm Therapeutics, holds 1.61M shares in Karyopharm Therapeutics (Ticker: KPTI), holds ― shares in Infinity Pharmaceuticals (Ticker: INFIQ), holds 8.88K shares in Verastem (Ticker: VSTM).
Michael Kauffman Karyopharm Therapeutics (KPTI)Director
Karyopharm Therapeutics (KPTI)
Director
Ranked #7,347 out of 99,218 Corporate Insiders
Profitable Transactions
8 out of 11 Profitable Transactions
Average Return
+20.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Kauffman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 13, 2015 - Jan 13, 2016
Return:+75.60%
The most profitable trade made by Michael Kauffman
Michael Kauffman's Trading History
Karyopharm Therapeutics
Mar 02, 2022
Director
Uninformative Buy
―
$1.41M
Infinity Pharmaceuticals
―
Director
―
―
Kezar Life Sciences
Jan 05, 2022
Director
Uninformative Buy
29.55K
$469.40K
Adicet Bio
Jun 07, 2024
Director
Uninformative Buy
―
$7.73K
Verastem
Jun 20, 2024
Director
Uninformative Buy
―
$35.09K
Onyx Pharma
―
―
―
―
Epirus Biopharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Michael Kauffman's performance on stock
You May Also Like
Michael Kauffman insider profile FAQ
What is the percentage of profitable transactions made by Michael Kauffman?
The percentage of profitable transactions made by Michael Kauffman is 73%.
What is the average return per transaction made by Michael Kauffman?
The average return per transaction made by Michael Kauffman is 20.80%.
What stocks does Michael Kauffman hold?
Michael Kauffman holds: KPTI, INFIQ, KZR, ACET, VSTM, ONXX, EPRSQ stocks.
What was Michael Kauffman’s latest transaction?
Michael Kauffman latest transaction was an Uninformative Buy of ―.
What was Michael Kauffman's most profitable transaction?
Michael Kauffman’s most profitable transaction was an Informative Sell of KPTI stock on January 13, 2015. The return on the trade was 75.60%.
What is Michael Kauffman's role in Karyopharm Therapeutics?
Michael Kauffman's role in Karyopharm Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.